Ashwagandha gummies, reviews:
what happened to the people who were given starch
When you look up reviews of ashwagandha gummies, you are really looking for the answer to a single question: will I feel anything? The honest answer is that even the people in the clinical trials could not tell that about themselves. In one of the most cited studies on the root extract, the group given starch capsules saw their perceived stress score fall from 22.70 to 16.63 in eight weeks. That is 69% of the drop seen in the group taking 600 mg of ashwagandha. Had you been in the starch group, you would have written a glowing review too.
A review is not evidence:
and with ashwagandha, it is not even weak evidence
Reviews are useful for things you can check from the outside. If someone writes that the jar arrived broken, that the gummies stuck together or that they taste too sweet, you can believe them. Those are observations about the object.
The problem starts when the review is about an inner state. Perceived stress, sleep quality, “mental clarity”: these are measured by self-assessment, and self-assessment shifts even when you are given nothing active. Not because people lie. Because they genuinely feel better.
The best example comes from the ashwagandha literature itself. In 2019, Salve, Pate, Debnath and Langade published a randomised, double-blind study in the journal Cureus on sixty healthy adults over eight weeks. Three arms: 250 mg of root extract a day, 600 mg a day, and a placebo arm given starch capsules. The authors state that they received no funding from any organisation for the submitted work.
| Group | What they were given | Perceived stress at baseline | Week 8 | How much it fell |
|---|---|---|---|---|
| Placebo | 125 mg starch twice a day | 22.70 | 16.63 | 6.07 points |
| Ashwagandha | 125 mg extract twice a day | 22.65 | 15.00 | 7.65 points |
| Ashwagandha | 300 mg extract twice a day | 22.95 | 14.15 | 8.80 points |
Look at the first row, not the last. The group taking starch reported a drop of 6.07 points. The high-dose group, 8.80. The ratio between them is 69%.
The difference the herb can claim, in its most favourable study, is 2.73 points. The other 6.07 would have happened anyway. A single review has no way of separating the two.
That is the whole argument of this article, stated once, in numbers. The rest is detail.
Two studies, the same extract:
and two placebo arms that look nothing alike
If the placebo response were a constant, you could subtract it and be left with the clean effect. It is not a constant. It is the most unstable number in the whole file.
In January 2026, Vani, Muralidhar and Srinivas Rao published a study in Frontiers in Reproductive Health on sixty women, thirty per arm, using the same KSM-66 root extract, the same total daily dose of 600 mg, again in capsules, for 56 days. The placebo arm started at 27.70 on the ten-item perceived stress scale and ended at 27.40. It moved by three tenths of a point.
Six point zero seven in one study. Zero point three in the other. The same extract, the same daily dose, almost the same duration, and a factor of twenty between the two arms that were given nothing.
Salve, Pate, Debnath and Langade, Cureus, 2019. Sixty healthy adults, eight weeks, three arms: 250 mg a day of root extract, 600 mg a day, and a placebo arm given capsules of 125 mg of starch, twice a day.
Perceived stress score in the placebo arm: 22.70 at baseline, 19.89 at week four, 16.63 at week eight. In the 600 mg arm: 22.95, then 18.85, then 14.15.
The authors state that they received no funding from any organisation for the submitted work. The study is clean. That is exactly why its placebo arm is so instructive.
Vani, Muralidhar and Srinivas Rao, Frontiers in Reproductive Health, 2026. Sixty women, thirty per arm, the same KSM-66 root extract, the same total daily dose of 600 mg, again in capsule form, 56 days.
Score on the ten-item perceived stress scale in the placebo arm: 27.70 at baseline, 27.40 on day 56. It moved by three tenths of a point.
The same extract, the same dose, almost the same duration. One placebo arm moved by 6.07 points, the other by 0.30. The difference does not come from the herb, because the herb was not even there.
Cheah, Norhayati, Husniati Yaacob and Abdul Rahman, PLOS ONE, 2021. A meta-analysis of five randomised trials and 400 participants, on the effect on sleep.
The result, in the authors' words: a “small but significant” effect, with a standardised effect size of 0.59 and heterogeneity of 62%. Heterogeneity of 62% means the studies do not agree with one another.
And the sentence that matters for this article: all five included studies used a placebo in capsule form. Four with starch powder, one with rice powder. None with gummies.
What this means in practice: the size of the “effect” someone feels depends enormously on who the person is, the context in which they start taking it and how strongly they expect it to work. Exactly the variables a review never declares.
Zero:
the number of clinical trials done on ashwagandha in gummy form
Every study we read for this article used capsules. The meta-analysis published by Cheah and colleagues in PLOS ONE in 2021, covering five randomised trials and 400 participants, says so directly: all five included studies used a placebo in capsule form, four with starch powder, one with rice powder. Langade's 2019 study describes a capsule with 300 mg of root extract. Vani's 2026 study describes a gelatine capsule, two a day, after meals.
We specifically searched for a clinical trial in humans on ashwagandha in gummy form. We did not find a single one. The health professional fact sheet from the US National Institutes of Health, which is the most complete public summary on this ingredient, does not mention gummies at all.
It does not mean that a gummy with 600 mg of extract contains anything different from a tablet with 600 mg of extract. The raw material is the same, and the declared amount is a declared amount in both cases.
It means nobody has measured it. The stability of withanolides in a pectin matrix with water and xylitol, over a two-year shelf life, is not a given. It is a question the manufacturer answers through batch testing.
The difference between “it does not work” and “it has not been measured” is the difference between an honest article and a convenient one. We sell gummies and we still write this.
600 mg is not a dose:
the withanolides are
Almost every box of ashwagandha in Romania carries a number of milligrams. That number describes how much extract is inside, not how much of the substances the studies track.
KSM-66 type root extracts are described in the literature as water-based, root-only extracts standardised to at least 5% withanolides, verified by high-performance liquid chromatography. The National Institutes of Health fact sheet frames its guidance in the same terms: between 300 and 600 mg of root extract standardised to 5% withanolides. In other words, the percentage is part of the dose.
And the number on the box is not comparable between products. Another extract often used in studies, Sensoril, is made from root and leaf and is dosed in the literature at between 125 and 500 mg a day. The same milligrams mean something else. If the label does not give you the standardisation percentage and the part of the plant, you cannot compare two products, however many reviews you read.
The name of the extract, the part of the plant, the withanolide standardisation percentage and the testing method. If three out of four are missing, the milligrams on the front are decoration.
Five common reviews:
and what is left of them when you look at the numbers
Maybe. But in the placebo arm of the Salve study, the perceived stress score had already fallen from 22.70 to 19.89 by week four, in people taking starch. The feeling of “it kicked in after three weeks” is exactly the feeling reported by people who are given nothing active. It is not a lie, it is just impossible to attribute.
The average rating measures how satisfied the people who chose to leave a review are, not how much the product did. For a supplement whose outcome is a subjective state, the rating is essentially a measure of expectation. A product with zero active substance, sold with a good story, can collect the same five stars.
For ashwagandha there is no human study comparing the two forms, so the claim has nothing to stand on. The only serious head-to-head comparison between gummies and tablets was done on vitamin D3, and we have written about it separately, including who paid for it.
600 mg is an amount of extract, not of active substance. Root extracts standardised to at least 5% withanolides provide around 30 mg of withanolides a day at 600 mg. Other extracts are made from root and leaf and are dosed between 125 and 500 mg. The same milligrams, different content.
The health professional fact sheet from the US National Institutes of Health describes five cases of liver injury in people who had taken between 450 and 1,350 mg a day, for between one week and four months. The LiverTox database gives ashwagandha a likelihood score of B, meaning a likely cause of clinically apparent liver injury.
Who it is not suitable for:
and why the dog at home matters
Ashwagandha is not for everyone. The health professional fact sheet from the US National Institutes of Health describes five cases of liver injury, three men and two women aged between 21 and 62, in people who had taken supplements with between 450 and 1,350 mg of ashwagandha a day, for periods of one week to four months. The LiverTox database assigns it a likelihood score of B, meaning a likely cause of clinically apparent liver injury, and notes that the number of reported cases has been rising since the first report in 2017. The same fact sheet notes that some experts recommend avoiding it during pregnancy. If you take psychiatric medication, sedatives, immunosuppressants or thyroid treatment, talk to your doctor before, not after.
We have written separate articles on the thyroid, on the contraceptive pill, on antidepressants and on pregnancy, each based on its own sources. They are in the list at the end.
There is one more thing that is not written anywhere, and it has to do with the gummy form, not the herb. Our gummies are sweetened with xylitol. In humans, xylitol is an ordinary polyol: above 10% polyols in a product, Annex III of Regulation (EU) No 1169/2011 requires the statement that excessive consumption may produce laxative effects. In dogs, it is a different story. The Merck Veterinary Manual associates doses above roughly 100 mg per kilogram with hypoglycaemia, and above 500 mg per kilogram with severe liver failure.
An ordinary polyol. Above the 10% threshold in a product, the warning about the laxative effect becomes mandatory on the label.
Hypoglycaemia associated from roughly 100 mg per kilogram. A jar of sweet gummies left on the table is an accident that happens often.
What it says on our box
and why exactly that much
This whole article says that a review does not tell you much, and that milligrams cannot be compared between products unless you know the standardisation. So here are the numbers on ours, so you can put them next to any others.
The serving is two gummies a day and contains 600 mg of KSM-66 root extract, standardised to 5% withanolides, which is roughly 30 mg of withanolides a day, with an extraction ratio of 10 to 15 to 1. The jar holds 60 gummies, which is 30 servings. They are sweetened with xylitol and set with citrus pectin, not gelatine. They are made in Romania.
These are the things a real comparison is made with: the part of the plant, the name of the extract, the standardisation percentage, the dose per serving. Without them, the “600 mg” on any box is a number that cannot be placed next to another number.
And, as everywhere in the chapters above: the gummy form has not been tested on its own in any clinical trial. What we can tell you with certainty is what you are putting in your mouth, not what you will feel.
Frequently asked questions:
seven short answers
Ashwagandha has no authorised health claim in the European Union, so no manufacturer is allowed to promise you an effect, and we do not promise you one. What can be said is what the studies measured, and that is where the problem appears: in Salve's 2019 study, the group given starch capsules reported 69% of the improvement reported by the 600 mg group. The real difference attributed to the herb was 2.73 points.
Because perceived stress is measured by self-assessment, and self-assessment shifts even when you are given nothing active. In the placebo arm of the Salve study, the score fell from 22.70 to 16.63 in eight weeks. Those people were convinced they felt better and they were right, just not because of the herb. A review cannot tell the difference.
None that we could find. The meta-analysis published by Cheah and colleagues in PLOS ONE in 2021 states explicitly that all five included studies used the capsule form. That does not mean the gummy does not work, it means nobody has measured it. It is an important difference and almost nobody writes it down.
It means 600 mg of extract, not 600 mg of active substance. KSM-66 type root extracts are standardised to at least 5% withanolides by liquid chromatography, so 600 mg means around 30 mg of withanolides a day. An extract standardised differently, or made from root and leaf, gives a different number for the same milligrams.
No. In the annex to Regulation (EU) 432/2012, which is the closed list of health claims permitted in the European Union, the word “ashwagandha” appears zero times, and “Withania” zero times. Any box, product page or article telling you the herb reduces stress, cortisol or anxiety is writing something it is not allowed to write.
Women who are pregnant or breastfeeding, people with thyroid or liver conditions, and anyone taking psychiatric medication, sedatives or immunosuppressants, without first talking to their doctor. The US National Institutes of Health fact sheet describes five cases of liver injury in people who had taken between 450 and 1,350 mg a day, for between one week and four months.
It does, especially if you have a dog at home. Our gummies are sweetened with xylitol. In humans, xylitol is an ordinary polyol, and above 10% polyols in a product the warning that excessive consumption may produce laxative effects becomes mandatory. In dogs, however, the Merck Veterinary Manual associates doses above about 100 mg per kilogram with hypoglycaemia. A jar of sweet gummies left within reach is a real risk.
Comments (0)
There are no comments for this article. Be the first one to leave a message!